A detailed history of Poinciana Advisors Group, LLC transactions in Incyte Corp stock. As of the latest transaction made, Poinciana Advisors Group, LLC holds 2,628 shares of INCY stock, worth $273,706. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,628
Previous 3,364 21.88%
Holding current value
$273,706
Previous $229 Million 2.71%
% of portfolio
0.19%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

SELL
$67.27 - $86.96 $49,510 - $64,002
-736 Reduced 21.88%
2,628 $223 Million
Q2 2025

Jul 17, 2025

BUY
$55.17 - $71.22 $185,591 - $239,584
3,364 New
3,364 $229 Million
Q4 2024

Feb 10, 2025

BUY
$65.08 - $83.38 $339,066 - $434,409
5,210 New
5,210 $360 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Poinciana Advisors Group, LLC Portfolio

Follow Poinciana Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Poinciana Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Poinciana Advisors Group, LLC with notifications on news.